Annual Cash & Cash Equivalents
$126.45 M
+$85.91 M+211.91%
December 31, 2023
Summary
- As of February 7, 2025, AMED annual cash & cash equivalents is $126.45 million, with the most recent change of +$85.91 million (+211.91%) on December 31, 2023.
- During the last 3 years, AMED annual cash & cash equivalents has risen by +$44.64 million (+54.57%).
- AMED annual cash & cash equivalents is now at all-time high.
Performance
AMED Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$245.45 M
+$95.57 M+63.76%
September 1, 2024
Summary
- As of February 7, 2025, AMED quarterly cash and cash equivalents is $245.45 million, with the most recent change of +$95.57 million (+63.76%) on September 1, 2024.
- Over the past year, AMED quarterly cash and cash equivalents has increased by +$119.00 million (+94.11%).
- AMED quarterly cash and cash equivalents is now at all-time high.
Performance
AMED Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AMED Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +211.9% | +94.1% |
| 3 y3 years | +54.6% | +396.5% |
| 5 y5 years | +525.1% | +396.5% |
AMED Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +211.9% | at high | +1267.0% |
| 5 y | 5-year | at high | +317.4% | at high | +1267.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Amedisys Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $245.45 M(+63.8%) |
| Jun 2024 | - | $149.88 M(+38.5%) |
| Mar 2024 | - | $108.23 M(-14.4%) |
| Dec 2023 | $126.45 M(+211.9%) | $126.45 M(+61.9%) |
| Sep 2023 | - | $78.11 M(-18.1%) |
| Jun 2023 | - | $95.38 M(+92.9%) |
| Mar 2023 | - | $49.44 M(+21.9%) |
| Dec 2022 | $40.54 M(-5.0%) | $40.54 M(+125.8%) |
| Sep 2022 | - | $17.96 M(-32.4%) |
| Jun 2022 | - | $26.57 M(-60.8%) |
| Mar 2022 | - | $67.83 M(+58.9%) |
| Dec 2021 | $42.69 M(-47.8%) | $42.69 M(-65.7%) |
| Sep 2021 | - | $124.46 M(+35.8%) |
| Jun 2021 | - | $91.65 M(+18.5%) |
| Mar 2021 | - | $77.34 M(-5.5%) |
| Dec 2020 | $81.81 M(+170.0%) | $81.81 M(-27.5%) |
| Sep 2020 | - | $112.90 M(-36.3%) |
| Jun 2020 | - | $177.28 M(+1.4%) |
| Mar 2020 | - | $174.76 M(+476.9%) |
| Dec 2019 | $30.29 M(+49.8%) | $30.29 M(+45.9%) |
| Sep 2019 | - | $20.76 M(+49.3%) |
| Jun 2019 | - | $13.90 M(+31.7%) |
| Mar 2019 | - | $10.55 M(-47.8%) |
| Dec 2018 | $20.23 M(-76.6%) | $20.23 M(+44.4%) |
| Sep 2018 | - | $14.01 M(-45.9%) |
| Jun 2018 | - | $25.90 M(-78.4%) |
| Mar 2018 | - | $120.00 M(+39.0%) |
| Dec 2017 | $86.36 M(+186.0%) | $86.36 M(+30.6%) |
| Sep 2017 | - | $66.11 M(+11.7%) |
| Jun 2017 | - | $59.16 M(+22.4%) |
| Mar 2017 | - | $48.33 M(+60.1%) |
| Dec 2016 | $30.20 M(+9.8%) | $30.20 M(+238.7%) |
| Sep 2016 | - | $8.91 M(-10.6%) |
| Jun 2016 | - | $9.97 M(+27.4%) |
| Mar 2016 | - | $7.82 M(-71.6%) |
| Dec 2015 | $27.50 M(+242.4%) | $27.50 M(-51.8%) |
| Sep 2015 | - | $57.05 M(+71.8%) |
| Jun 2015 | - | $33.20 M(+960.1%) |
| Mar 2015 | - | $3.13 M(-61.0%) |
| Dec 2014 | $8.03 M(-53.6%) | $8.03 M(+44.9%) |
| Sep 2014 | - | $5.54 M(-50.6%) |
| Jun 2014 | - | $11.22 M(+295.2%) |
| Mar 2014 | - | $2.84 M(-83.6%) |
| Dec 2013 | $17.30 M(+19.0%) | $17.30 M(-60.3%) |
| Sep 2013 | - | $43.63 M(+44.9%) |
| Jun 2013 | - | $30.12 M(+329.0%) |
| Mar 2013 | - | $7.02 M(-51.7%) |
| Dec 2012 | $14.54 M(-69.7%) | $14.54 M(-62.8%) |
| Sep 2012 | - | $39.11 M(+5.2%) |
| Jun 2012 | - | $37.16 M(-10.0%) |
| Mar 2012 | - | $41.29 M(-14.0%) |
| Dec 2011 | $48.00 M(-60.1%) | $48.00 M(+62.9%) |
| Sep 2011 | - | $29.46 M(+4.7%) |
| Jun 2011 | - | $28.13 M(-81.1%) |
| Mar 2011 | - | $148.87 M(+23.8%) |
| Dec 2010 | $120.30 M(+248.8%) | $120.30 M(+3.7%) |
| Jun 2010 | - | $116.03 M(+41.5%) |
| Mar 2010 | - | $81.98 M(+137.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $34.48 M(+1111.3%) | $34.48 M(-23.6%) |
| Sep 2009 | - | $45.16 M(+4929.0%) |
| Jun 2009 | - | $898.00 K(-96.5%) |
| Mar 2009 | - | $25.65 M(+800.9%) |
| Dec 2008 | $2.85 M(-94.9%) | $2.85 M(-49.7%) |
| Sep 2008 | - | $5.66 M(+241.2%) |
| Jun 2008 | - | $1.66 M(-93.4%) |
| Mar 2008 | - | $25.24 M(-55.1%) |
| Dec 2007 | $56.19 M(-33.3%) | $56.19 M(-15.6%) |
| Sep 2007 | - | $66.59 M(-27.1%) |
| Jun 2007 | - | $91.34 M(-15.0%) |
| Mar 2007 | - | $107.48 M(+27.6%) |
| Dec 2006 | $84.22 M(+388.8%) | $84.22 M(+754.6%) |
| Sep 2006 | - | $9.86 M(+23.9%) |
| Jun 2006 | - | $7.96 M(-16.0%) |
| Mar 2006 | - | $9.48 M(-45.0%) |
| Dec 2005 | $17.23 M(-80.8%) | $17.23 M(-17.0%) |
| Sep 2005 | - | $20.75 M(-71.2%) |
| Jun 2005 | - | $72.06 M(-8.7%) |
| Mar 2005 | - | $78.92 M(-12.0%) |
| Dec 2004 | $89.68 M(+201.1%) | $89.68 M(-3.8%) |
| Sep 2004 | - | $93.18 M(+318.2%) |
| Jun 2004 | - | $22.28 M(-8.5%) |
| Mar 2004 | - | $24.34 M(-18.3%) |
| Dec 2003 | $29.78 M(+512.6%) | $29.78 M(+195.9%) |
| Sep 2003 | - | $10.06 M(-21.4%) |
| Jun 2003 | - | $12.80 M(+53.5%) |
| Mar 2003 | - | $8.34 M(+71.6%) |
| Dec 2002 | $4.86 M(+38.3%) | $4.86 M(-56.2%) |
| Sep 2002 | - | $11.09 M(+11.8%) |
| Jun 2002 | - | $9.92 M(+325.1%) |
| Mar 2002 | - | $2.33 M(-33.6%) |
| Dec 2001 | $3.52 M(-49.5%) | $3.52 M(+5.1%) |
| Sep 2001 | - | $3.35 M(-12.5%) |
| Jun 2001 | - | $3.82 M(-68.7%) |
| Mar 2001 | - | $12.21 M(+75.2%) |
| Dec 2000 | $6.97 M(+388.9%) | $6.97 M(+50.5%) |
| Sep 2000 | - | $4.63 M(-3.2%) |
| Jun 2000 | - | $4.78 M(+277.3%) |
| Mar 2000 | - | $1.27 M(+121.5%) |
| Dec 1999 | $1.43 M(+149.1%) | - |
| Dec 1998 | $572.00 K(-85.9%) | $572.00 K(+14.4%) |
| Jun 1998 | - | $500.00 K(-61.5%) |
| Mar 1998 | - | $1.30 M(-68.1%) |
| Dec 1997 | $4.07 M(+268.6%) | $4.07 M(+50.7%) |
| Sep 1997 | - | $2.70 M(+8.0%) |
| Jun 1997 | - | $2.50 M(+92.3%) |
| Mar 1997 | - | $1.30 M(+17.7%) |
| Dec 1996 | $1.10 M(+22.7%) | $1.10 M(-54.0%) |
| Sep 1996 | - | $2.40 M(+500.0%) |
| Jun 1996 | - | $400.00 K(0.0%) |
| Mar 1996 | - | $400.00 K(-55.6%) |
| Dec 1995 | $900.00 K(+350.0%) | $900.00 K(+50.0%) |
| Sep 1995 | - | $600.00 K(+200.0%) |
| Jun 1995 | - | $200.00 K(0.0%) |
| Dec 1994 | $200.00 K(-81.8%) | $200.00 K(-50.0%) |
| Jun 1994 | - | $400.00 K(-42.9%) |
| Mar 1994 | - | $700.00 K(-36.4%) |
| Dec 1993 | $1.10 M | $1.10 M |
FAQ
- What is Amedisys annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Amedisys?
- What is Amedisys annual cash & cash equivalents year-on-year change?
- What is Amedisys quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Amedisys?
- What is Amedisys quarterly cash and cash equivalents year-on-year change?
What is Amedisys annual cash & cash equivalents?
The current annual cash & cash equivalents of AMED is $126.45 M
What is the all time high annual cash & cash equivalents for Amedisys?
Amedisys all-time high annual cash & cash equivalents is $126.45 M
What is Amedisys annual cash & cash equivalents year-on-year change?
Over the past year, AMED annual cash & cash equivalents has changed by +$85.91 M (+211.91%)
What is Amedisys quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AMED is $245.45 M
What is the all time high quarterly cash and cash equivalents for Amedisys?
Amedisys all-time high quarterly cash and cash equivalents is $245.45 M
What is Amedisys quarterly cash and cash equivalents year-on-year change?
Over the past year, AMED quarterly cash and cash equivalents has changed by +$119.00 M (+94.11%)